Montelukast 10 mg

DRUG4 trials

Sponsors

Merck Sharp & Dohme LLC, GlaxoSmithKline, ViiV Healthcare

Conditions

AsthmaHIV Infections

Phase 1

Bioequivalence Study of Montelukast 10 mg Tablets

CompletedNCT01943942

GlaxoSmithKlineAsthma

Start: 2010-05-16End: 2010-05-26Updated: 2017-06-15

Evaluation of Pharmacokinetic Interaction Between GSK3640254 and Caffeine, Metoprolol, Montelukast, Flurbiprofen, Omeprazole, Midazolam, Digoxin, and Pravastatin in Healthy Adults

CompletedNCT04425902

ViiV HealthcareHIV Infections

Start: 2020-12-16End: 2021-03-10Updated: 2024-01-05

Phase 2

A Dose-Ranging Study of MK-1029 in Adults With Persistent Asthma (MK-1029-012)

TerminatedNCT01656395

Merck Sharp & Dohme LLCAsthma

Start: 2012-08-23End: 2014-07-08Updated: 2018-09-13

Study of MK-1029 in Participants With Persistent Asthma That Cannot Be Controlled With Montelukast (MK-1029-015)

CompletedNCT02720081

Merck Sharp & Dohme LLCAsthma

Start: 2016-05-11End: 2017-09-06Updated: 2018-09-27